12 Health Care Stocks Moving In Monday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's after-market session, several health care stocks experienced significant price movements. Conduit Pharmaceuticals, TNF Pharmaceuticals, and Holdco Nuvo Group DG were among the top gainers, while Renalytix, Bluejay Diagnostics, and IO Biotech saw notable declines.
September 02, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bluejay Diagnostics' stock decreased by 13.46% in after-market trading.
The sharp decline in BJDX's stock price suggests negative investor sentiment, likely resulting in a short-term negative impact.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
IO Biotech's stock fell by 10.67% in the after-market session.
The decline in IOBT's stock price indicates a negative outlook, likely leading to a short-term downward trend.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Renalytix shares declined by 13.8% in the after-market session.
The significant decline in RNLX's stock price indicates negative sentiment or news, likely leading to a short-term downward trend.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Conduit Pharmaceuticals saw a significant increase of 27.4% in its stock price during Monday's after-market session.
The substantial increase in CDT's stock price suggests positive investor sentiment or news, likely leading to a short-term upward trend.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Holdco Nuvo Group DG experienced a 17.64% increase in its stock price after-market.
The notable increase in NUVO's stock price suggests a positive outlook, likely leading to a short-term upward trend.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
TNF Pharmaceuticals' stock rose by 18.82% in the after-market session.
The significant rise in TNFA's stock price indicates strong investor interest, likely resulting in a short-term positive impact.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100